Full Text View
Tabular View
Study Results
Related Studies
Renal Safety of Iopamidol Versus Iodixanol During Coronary Angiography in Diabetic Patients (RECARE)
This study has been terminated.
( This study was terminated early due to slow enrollment. )
Study NCT00782639   Information provided by Bracco Diagnostics, Inc

First Received on October 28, 2008.   Last Updated on January 24, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chronic Renal Impairment
Diabetes Mellitus
Additional conditions recognized in this trial
Renal Insufficiency
Renal Insufficiency, Chronic
More general conditions related to this trial
Endocrine System Diseases
Glucose Metabolism Disorders
Kidney Diseases
Metabolic Diseases
Urologic Diseases
Interventions listed in this trial
Iopamidol injection 76%
iodixanol
Sponsors listed in this trial
Bracco Diagnostics, Inc


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services